FDQ-22366-15637
4 vaccinations
17 coded responses
43 check-ins
17 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 168 / PA
- Registered
- 2021-02-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-03
Dose 1 — Pfizer-BioNTech
-
2021-02-24
Registered in v-safe
-
2021-02-24
Dose 2 — Pfizer-BioNTech
- 2021-02-24
-
2021-02-25
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-26
Survey response — days 1–6 daily, dose 2MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: L axillary lymph node swollen and tenderMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-02-28
Survey response — days 1–6 daily, dose 2MedDRA: Erythema, Lymphadenopathy — Feeling: Good · Site: Pain, Redness, SwellingFree text: L axillary and L medial upper arm swollen lymph node and rednessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-01
Survey response — days 1–6 daily, dose 2MedDRA: Erythema, Lymphadenopathy — Feeling: Good · Site: PainFree text: Decreased redness; still L medial arm and axillary lymph node enlargedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-02
Survey response — days 1–6 daily, dose 2MedDRA: Injection site erythema, Injection site swelling, Injection site warmth, Lymphadenopathy, Medical counselling — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Systemic reaction (other): Swelling and redness distal to injection site - mid arm) with L upper arm and axillary enlarged lymph nodes. Contacted physician and diagnosed with local reactive lymphadenopathy · Healthcare visit (other): For waxing /waning redness/warmth distal to injection site with enlarged lymph nodes ipsilateral arm and axillary- diagnosed with local reactive lymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-02
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-03
Survey response — day 7, dose 2MedDRA: Erythema — Feeling: GoodFree text: Slight redness distal to injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-10
- 2021-03-17
- 2021-03-24
- 2021-03-31
- 2021-04-07
- 2021-05-26
- 2021-08-25
- 2021-09-21
-
2021-10-28
Dose 3 — Pfizer-BioNTech
-
2021-10-28
Health check-in — day 0, dose 3Feeling: Good · Site: Pain, Swelling · Chills, Headache, Fatigue or tirednessAdult check-in
-
2021-10-29
Survey response — days 1–6 daily, dose 3MedDRA: Cough, Respiratory tract congestion — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Congestion , intermittent coughMedDRA releases: 2024-11 · check-in free text available
-
2021-10-30
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Lymph node swelling -same side as injection siteMedDRA releases: 2024-11 · check-in free text available
-
2021-10-31
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · Chills, Fatigue or tirednessFree text: Left axilla lymph node swellingMedDRA releases: 2024-11 · check-in free text available
-
2021-11-01
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: L axillary lymph node swellingMedDRA releases: 2024-11 · check-in free text available
-
2021-11-02
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-11-03
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: L axillary lymph node swellingMedDRA releases: 2024-11 · check-in free text available
-
2021-11-04
Survey response — day 7, dose 3MedDRA: Lymphadenopathy — Feeling: GoodFree text: L axillary lymph node swelling-mildMedDRA releases: 2024-11 · check-in free text available
- 2021-11-11
- 2021-11-18
- 2021-11-25
- 2021-12-02
- 2021-12-09
- 2022-01-27
- 2022-04-28
-
2022-09-16
Dose 4 — Pfizer-BioNTech
-
2022-09-17
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-09-18
Survey response — days 1–6 daily, dose 4MedDRA: Lymphoedema — Feeling: Fair · Site: Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: L axillary lymphedemaMedDRA releases: 2024-11 · check-in free text available
-
2022-09-19
Survey response — days 1–6 daily, dose 4MedDRA: Lymphoedema — Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessFree text: L axillary lymphedemaMedDRA releases: 2024-11 · check-in free text available
-
2022-09-21
Survey response — days 1–6 daily, dose 4MedDRA: Lymphoedema — Feeling: GoodFree text: L axillary lymphedemaMedDRA releases: 2024-11 · check-in free text available
-
2022-09-22
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: GoodFree text: L axillary lymph node swellingMedDRA releases: 2024-11 · check-in free text available
-
2022-09-23
Survey response — day 7, dose 4MedDRA: Lymphadenopathy — Feeling: GoodFree text: L axillary lymph node swelling mildMedDRA releases: 2024-11 · check-in free text available
- 2022-09-30
-
2022-10-09
Survey response — day 21, dose 4MedDRA: Nasal congestion — Feeling: FairFree text: Nasal congestionMedDRA releases: 2024-11 · check-in free text available
- 2022-10-14
- 2022-10-21
- 2022-10-28
- 2022-12-16
- 2023-03-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-03 | Pfizer-BioNTech | |
| 2 | 2021-02-24 | Pfizer-BioNTech | |
| 3 | 2021-10-28 | Pfizer-BioNTech | No |
| 4 | 2022-09-16 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
1 wait over 3 months for a first call
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): L axillary lymph node swollen and tender
Systemic reaction (other): L axillary and L medial upper arm swollen lymph node and redness
Systemic reaction (other): Decreased redness; still L medial arm and axillary lymph node enlarged
Systemic reaction (other): Swelling and redness distal to injection site - mid arm) with L upper arm and axillary enlarged lymph nodes. Contacted physician and diagnosed with local reactive lymphadenopathy
Healthcare visit (other): For waxing /waning redness/warmth distal to injection site with enlarged lymph nodes ipsilateral arm and axillary- diagnosed with local reactive lymphadenopathy
Release 4 — day 7, dose 2
Systemic reaction (other): Slight redness distal to injection site
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Congestion , intermittent cough
Systemic reaction (other): Lymph node swelling -same side as injection site
Systemic reaction (other): Left axilla lymph node swelling
Systemic reaction (other): L axillary lymph node swelling
Systemic reaction (other): L axillary lymph node swelling
Release 10 — day 7, dose 3
Systemic reaction (other): L axillary lymph node swelling-mild
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): L axillary lymphedema
Systemic reaction (other): L axillary lymphedema
Systemic reaction (other): L axillary lymphedema
Systemic reaction (other): L axillary lymph node swelling
Release 12 — day 7, dose 4
Systemic reaction (other): L axillary lymph node swelling mild
Release 12 — day 21, dose 4
Symptoms: Nasal congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Injection site erythema | ✓ | ✓ | ✓ |
| HCVO | Injection site warmth | ✓ | ✓ | ✓ |
| HCVO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | Erythema | ✓ | ✓ | ✓ |
| SRO | Injection site erythema | ✓ | ✓ | ✓ |
| SRO | Injection site swelling | ✓ | ✓ | ✓ |
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Lymphoedema | · | · | ✓ |
| SRO | Medical counselling | ✓ | ✓ | ✓ |
| SRO | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release